Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

In Memoriam, Fred Gordin, MD, 1951-2018.

Cohn DL, El Sadr WM, Abrams DI, Neaton JD, Benator DA, Vernon AA.

Clin Infect Dis. 2018 Jun 18;67(1):153. doi: 10.1093/cid/ciy338. No abstract available.

PMID:
29846556
2.

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

Abrams DI.

Eur J Intern Med. 2018 Mar;49:7-11. doi: 10.1016/j.ejim.2018.01.003. Epub 2018 Jan 9. Review.

PMID:
29325791
3.

Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma.

Chao C, Silverberg MJ, Chen LH, Xu L, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J.

Leuk Lymphoma. 2018 Feb;59(2):321-329. doi: 10.1080/10428194.2017.1334121. Epub 2017 Jun 13.

PMID:
28610450
4.

Perceived Stress in Patients with Common Gastrointestinal Disorders: Associations with Quality of Life, Symptoms and Disease Management.

Edman JS, Greeson JM, Roberts RS, Kaufman AB, Abrams DI, Dolor RJ, Wolever RQ.

Explore (NY). 2017 Mar - Apr;13(2):124-128. doi: 10.1016/j.explore.2016.12.005. Epub 2016 Dec 16.

PMID:
28094229
5.

Long-term survival in AIDS-related primary central nervous system lymphoma.

Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL.

Neuro Oncol. 2017 Jan;19(1):99-108. doi: 10.1093/neuonc/now155. Epub 2016 Aug 30.

6.

Using Medical Cannabis in an Oncology Practice.

Abrams DI.

Oncology (Williston Park). 2016 May;30(5):397-404. No abstract available.

7.

Integrating cannabis into clinical cancer care.

Abrams DI.

Curr Oncol. 2016 Mar;23(2):S8-S14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.

8.

Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: study protocol.

Dusek JA, Abrams DI, Roberts R, Griffin KH, Trebesch D, Dolor RJ, Wolever RQ, McKee MD, Kligler B.

BMC Complement Altern Med. 2016 Feb 4;16:53. doi: 10.1186/s12906-016-1025-0.

9.

Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, Johnson M, Sacks HS.

J Pain. 2015 Dec;16(12):1221-1232. doi: 10.1016/j.jpain.2015.07.009. Epub 2015 Sep 9. Review.

10.

Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.

Chao C, Xu L, Silverberg MJ, Martínez-Maza O, Chen LH, Castor B, Abrams DI, Zha HD, Haque R, Said J.

AIDS. 2015 Sep 24;29(15):1943-51. doi: 10.1097/QAD.0000000000000780.

11.

Integrative Medicine Patients Have High Stress, Pain, and Psychological Symptoms.

Wolever RQ, Goel NS, Roberts RS, Caldwell K, Kligler B, Dusek JA, Perlman A, Dolor R, Abrams DI.

Explore (NY). 2015 Jul-Aug;11(4):296-303. doi: 10.1016/j.explore.2015.04.003. Epub 2015 Apr 30.

PMID:
26044918
12.

Cannabis in cancer care.

Abrams DI, Guzman M.

Clin Pharmacol Ther. 2015 Jun;97(6):575-86. doi: 10.1002/cpt.108. Epub 2015 Apr 17. Review.

13.

Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.

Marcus JL, Chao C, Leyden WA, Xu L, Yu J, Horberg MA, Klein D, Towner WJ, Quesenberry CP Jr, Abrams DI, Silverberg MJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1167-73. doi: 10.1158/1055-9965.EPI-14-1079. Epub 2015 Feb 24.

14.

A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.

Chao C, Silverberg MJ, Xu L, Chen LH, Castor B, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J.

Clin Cancer Res. 2015 Mar 15;21(6):1429-37. doi: 10.1158/1078-0432.CCR-14-2083. Epub 2015 Jan 14.

15.

Milking the evidence: diet does matter.

Abrams DI.

J Clin Oncol. 2014 Aug 1;32(22):2290-2. doi: 10.1200/JCO.2014.56.6299. Epub 2014 Jun 23. No abstract available.

PMID:
24958828
16.

Characteristics of cancer patients presenting to an integrative medicine practice-based research network.

Edman JS, Roberts RS, Dusek JA, Dolor R, Wolever RQ, Abrams DI.

Integr Cancer Ther. 2014 Sep;13(5):405-10. doi: 10.1177/1534735414537876. Epub 2014 Jun 9.

PMID:
24913179
17.

Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Wang CC, Silverberg MJ, Abrams DI.

Curr Infect Dis Rep. 2014 Jun;16(6):406. doi: 10.1007/s11908-014-0406-0.

18.

Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.

Marcus JL, Chao CR, Leyden WA, Xu L, Klein DB, Horberg MA, Towner WJ, Quesenberry CP Jr, Abrams DI, Van Den Eeden SK, Silverberg MJ.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):495-502. doi: 10.1097/QAI.0000000000000202.

PMID:
24820107
19.

Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group.

BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471.

20.

The BraveNet prospective observational study on integrative medicine treatment approaches for pain.

Abrams DI, Dolor R, Roberts R, Pechura C, Dusek J, Amoils S, Amoils S, Barrows K, Edman JS, Frye J, Guarneri E, Kligler B, Monti D, Spar M, Wolever RQ.

BMC Complement Altern Med. 2013 Jun 24;13:146. doi: 10.1186/1472-6882-13-146.

21.

It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients.

Messina M, Caan BJ, Abrams DI, Hardy M, Maskarinec G.

Oncology (Williston Park). 2013 May;27(5):430-7. Review.

22.

Integrating dietary supplements into cancer care.

Frenkel M, Abrams DI, Ladas EJ, Deng G, Hardy M, Capodice JL, Winegardner MF, Gubili JK, Yeung KS, Kussmann H, Block KI.

Integr Cancer Ther. 2013 Sep;12(5):369-84. doi: 10.1177/1534735412473642. Epub 2013 Feb 25. Review.

PMID:
23439656
23.

Patients seek integrative medicine for preventive approach to optimize health.

Wolever RQ, Abrams DI, Kligler B, Dusek JA, Roberts R, Frye J, Edman JS, Amoils S, Pradhan E, Spar M, Gaudet T, Guarneri E, Homel P, Amoils S, Lee RA, Berman B, Monti DA, Dolor R.

Explore (NY). 2012 Nov-Dec;8(6):348-52. doi: 10.1016/j.explore.2012.08.005.

PMID:
23141791
24.

Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men.

Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K.

AIDS Res Treat. 2012;2012:103072. doi: 10.1155/2012/103072. Epub 2012 Aug 27.

25.

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Quesenberry CP Jr, Abrams DI, Silverberg MJ.

AIDS. 2012 Nov 13;26(17):2223-31. doi: 10.1097/QAD.0b013e32835935b3.

26.

Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.

Chao C, Silverberg MJ, Martínez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, McGuire M, Xu L, Said J.

Clin Cancer Res. 2012 Sep 1;18(17):4702-12. Epub 2012 Jun 18.

27.

What's the alternative?

Abrams DI, Weil AT.

N Engl J Med. 2012 Jun 7;366(23):2232-3; author reply 2233. doi: 10.1056/NEJMc1204036. No abstract available.

28.

Massage for children undergoing hematopoietic cell transplantation: a qualitative report.

Ackerman SL, Lown EA, Dvorak CC, Dunn EA, Abrams DI, Horn BN, Degelman M, Cowan MJ, Mehling WE.

Evid Based Complement Alternat Med. 2012;2012:792042. doi: 10.1155/2012/792042. Epub 2012 Feb 23.

29.

Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial.

Mehling WE, Lown EA, Dvorak CC, Cowan MJ, Horn BN, Dunn EA, Acree M, Abrams DI, Hecht FM.

Evid Based Complement Alternat Med. 2012;2012:450150. doi: 10.1155/2012/450150. Epub 2012 Feb 9.

30.

HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. doi: 10.1158/1055-9965.EPI-11-0777. Epub 2011 Nov 22.

31.

Cannabinoid-opioid interaction in chronic pain.

Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL.

Clin Pharmacol Ther. 2011 Dec;90(6):844-51. doi: 10.1038/clpt.2011.188. Epub 2011 Nov 2.

PMID:
22048225
32.

Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

McCulloch M, Broffman M, van der Laan M, Hubbard A, Kushi L, Abrams DI, Gao J, Colford JM Jr.

Integr Cancer Ther. 2011 Sep;10(3):240-59. doi: 10.1177/1534735411406539. Epub 2011 Sep 30.

33.

Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy.

Abrams DI, Couey P, Shade SB, Kelly ME, Kamanu-Elias N, Stamets P.

BMC Complement Altern Med. 2011 Aug 10;11:60. doi: 10.1186/1472-6882-11-60.

34.

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.

Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ.

AIDS. 2011 Sep 10;25(14):1771-7. doi: 10.1097/QAD.0b013e328349c67a.

35.

Cannabis in palliative medicine: improving care and reducing opioid-related morbidity.

Carter GT, Flanagan AM, Earleywine M, Abrams DI, Aggarwal SK, Grinspoon L.

Am J Hosp Palliat Care. 2011 Aug;28(5):297-303. doi: 10.1177/1049909111402318. Epub 2011 Mar 28. Review.

PMID:
21444324
36.

Can clinicians now assure their breast cancer patients that soyfoods are safe?

Messina M, Abrams DI, Hardy M.

Womens Health (Lond). 2010 May;6(3):335-8. doi: 10.2217/whe.10.20. No abstract available.

PMID:
20426596
37.

Not soy simple.

Abrams DI.

J Soc Integr Oncol. 2010 Winter;8(1):1-2. No abstract available.

PMID:
20205983
38.

New insights into the role of HIV infection on cancer risk.

Silverberg MJ, Chao C, Abrams DI.

Lancet Oncol. 2009 Dec;10(12):1133-4. doi: 10.1016/S1470-2045(09)70336-5. No abstract available.

PMID:
19959070
39.

HIV infection and the risk of cancers with and without a known infectious cause.

Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI.

AIDS. 2009 Nov 13;23(17):2337-45. doi: 10.1097/QAD.0b013e3283319184.

40.

Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S; Society for Integrative Oncology.

J Soc Integr Oncol. 2009 Summer;7(3):85-120. No abstract available.

PMID:
19706235
41.

Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Silverberg MJ, Abrams DI.

Curr Opin HIV AIDS. 2009 Jan;4(1):42-51. doi: 10.1097/COH.0b013e32831a9875.

42.

Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer.

Lee J, Dodd MJ, Dibble SL, Abrams DI.

Oncol Nurs Forum. 2008 Sep;35(5):830-5. doi: 10.1188/08.ONF.830-835.

PMID:
18765330
43.

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3.

44.

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76.

45.

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.

Silverberg MJ, Abrams DI.

Curr Opin Oncol. 2007 Sep;19(5):446-51. Review.

PMID:
17762569
46.

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI.

AIDS. 2007 Sep 12;21(14):1957-63.

PMID:
17721103
47.

Vaporization as a smokeless cannabis delivery system: a pilot study.

Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL.

Clin Pharmacol Ther. 2007 Nov;82(5):572-8. Epub 2007 Apr 11.

PMID:
17429350
48.

An overview of integrative oncology.

Abrams DI.

Clin Adv Hematol Oncol. 2007 Jan;5(1):45-7. No abstract available.

PMID:
17339827
49.

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL.

Neurology. 2007 Feb 13;68(7):515-21.

PMID:
17296917
50.

Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study.

Abrams DI, Shade SB, Couey P, McCune JM, Lo J, Bacchetti P, Chang B, Epling L, Liegler T, Grant RM.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):77-85.

PMID:
17263636

Supplemental Content

Loading ...
Support Center